It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Roivant Sciences Ltd. (ROIV) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $11.79. The Roivant Sciences Ltd. has recorded 12,121 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants.
Roivant Sciences Ltd. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $11.79 and fluctuated between $11.87 as its day high and $11.45 as its day low. The current market capitalization of Roivant Sciences Ltd. is $9.01B. A total of 2.25 million shares were traded on the day, compared to an average of 5.06M shares.
In the most recent transaction, Venker Eric sold 5,926 shares of ROIV for 11.85 per share on Sep 06. After the transaction, the Chief Operating Officer now owns 611,813 company shares. In a previous transaction on Sep 05, Venker Eric sold 73,275 shares at 11.92 per share. ROIV shares that Chief Operating Officer owns now total 611,813.
Among the insiders who sold shares, Venker Eric disposed of 14,763 shares on Sep 01 at a per-share price of $11.90. This resulted in the Chief Operating Officer holding 611,813 shares of ROIV after the transaction. In another insider transaction, Venker Eric sold 59,811 shares at $11.89 per share on Aug 14. Company shares held by the Chief Operating Officer now total 627,918.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for ROIV in the last 3 months, the mean price target is $15.88 with high estimates of $23.00 and low estimates of $12.00. In terms of 52-week highs and lows, ROIV has a high of $12.01 and a low of $2.87.
As of this writing, ROIV has an earnings estimate of -$0.29 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.33. The company reported an EPS of -$0.2 in the last quarter, which was 44.40% higher than expectations of -$0.36.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ROIV’s latest balance sheet shows that the firm has $2.07B in Cash & Short Term Investments as of fiscal 2022. There were $283.89M in debt and $184.37M in liabilities at the time. Its Book Value Per Share was $1.20, while its Total Shareholder’s Equity was $2.04B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ROIV is Buy with a score of 4.78.